US STOCKS-S&P 500 hits record again; Actavis rallies
* SunEdison, TerraForm rally on entrance to U.S. wind power market
* German analyst and investor sentiment up in November
* U.S. producer inflation up but underlying trend muted
* Indexes up: Dow 0.1 pct, S&P 0.3 pct, Nasdaq 0.5 pct (Updates prices, changes comment)
By Rodrigo Campos
NEW YORK, Nov 18 (Reuters) - U.S. stocks rose on Tuesday, lifting the S&P 500 to a record high, boosted by healthcare after Actavis' acquisition of Allergan triggered bullish analyst notes.
Further support for equities came from U.S. producer prices that kept intact a trend of benign inflation and from higher homebuilder sentiment in November, while German analyst and investor sentiment advanced this month for the first time in almost a year.
The S&P 500 has risen in seven of the past eight sessions, but its largest gain was of less than 0.4 percent and overall volume has been low. The index gains on Tuesday stopped right at the 2,050 level.
Allergan on Monday accepted a $66 billion takeover bid from Actavis Plc in cash and stock. At least two analysts raised Actavis' price target, one to as high as $300. Actavis shares rose Tuesday 5.3 percent to $261.16 as the top percentage gainer on the S&P 500. Continuación...